| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 13.64▼ | 13.58▲ | 13.57▲ | 12.90▲ | 13.31▲ |
| MA10 | 13.60▲ | 13.59▲ | 13.37▲ | 13.05▲ | 13.51▲ |
| MA20 | 13.57▲ | 13.30▲ | 12.88▲ | 13.23▲ | 14.93▼ |
| MA50 | 13.60▲ | 12.80▲ | 12.77▲ | 13.76▼ | 23.91▼ |
| MA100 | 13.33▲ | 12.80▲ | 13.30▲ | 15.37▼ | 30.40▼ |
| MA200 | 12.84▲ | 13.26▲ | 13.49▲ | 21.91▼ | 4,120.56▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | -0.001▼ | 0.103▲ | 0.024▲ | 0.573▲ |
| RSI | 54.322▲ | 65.973▲ | 68.943▲ | 51.507▲ | 41.292▼ |
| STOCH | 67.222 | 51.576 | 78.389 | 29.148 | 25.838 |
| WILL %R | -38.889 | -23.902▲ | -14.894▲ | -36.508 | -71.958 |
| CCI | 42.710 | 41.279 | 73.223 | 19.255 | -76.117 |
|
Wednesday, April 29, 2026 04:15 AM
Company on track to initiate a randomized, double-blind, placebo-controlled, adaptive Phase 2 field study in the first half of 2027, pending FDA ...
|
|
Tuesday, April 28, 2026 07:04 PM
Reports Phase 1 Data And Plans Phase 2 Study For Lyme Disease Prevention Candidate. Tonix Pharmaceuticals (NASDAQ: TNXP) announced the presentation of Phase 1 data and plans for an adaptive Phase 2 ...
|
|
Thursday, April 23, 2026 11:34 PM
Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/26 | 12.90 | 13.8499 | 12.90 | 13.60 | 349,236 |
| 30/04/26 | 12.30 | 12.975 | 12.21 | 12.93 | 272,392 |
| 29/04/26 | 12.56 | 12.66 | 12.00 | 12.40 | 306,188 |
| 28/04/26 | 12.55 | 12.89 | 12.55 | 12.71 | 277,142 |
| 27/04/26 | 12.75 | 13.05 | 12.6167 | 12.84 | 236,577 |
| 24/04/26 | 12.56 | 12.8099 | 12.35 | 12.61 | 275,013 |
| 23/04/26 | 13.12 | 13.1789 | 12.34 | 12.49 | 368,795 |
| 22/04/26 | 13.65 | 13.685 | 12.965 | 13.11 | 396,051 |
| 21/04/26 | 14.32 | 14.35 | 13.48 | 13.51 | 293,673 |
| 20/04/26 | 13.83 | 14.44 | 13.70 | 14.34 | 308,382 |
|
|
||||
|
|
||||
|
|